RxDoctor Payments Data

Brian Moseley

Neurology · Cincinnati, OHNPI 1407010382

Payments from drug & device makers

$225,673in general payments, 2019–2025

Across 391 payments — averaging $577.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$92K
  • Livanova USA, Inc.$55K
  • UCB, Inc.$47K
  • UCB SA$18K
  • UCB Biosciences Inc.$7K
  • Sunovion Pharmaceuticals Inc.$6K
$20,020in research payments, 2019–2025

Across 4 payments — averaging $5005.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$17K
  • UCB, Inc.$3K

What the payments were for

  • Consulting fees$21,29010%
  • Speaking & faculty fees$160,39073%
  • Travel & lodging$31,70714%
  • Food & beverage$6,1863%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.157$92,112
Livanova USA, Inc.102$55,499
UCB, Inc.80$46,639
UCB SA31$18,023
UCB Biosciences Inc.14$7,289
Sunovion Pharmaceuticals Inc.7$6,111

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$225,673 in reported general payments places this provider in the 85th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio

Other neurology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →